ArticleMolecules (Basel, Switzerland)2022

Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells.

Claudio Tabolacci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.